BVNKF
Price
$21.20
Change
-$0.00 (-0.00%)
Updated
May 17, 6:59 PM EST
BVNRY
Price
$8.65
Change
+$0.27 (+3.22%)
Updated
May 17, 6:59 PM EST
Ad is loading...

BVNKF vs BVNRY

Header iconBVNKF vs BVNRY Comparison
Open Charts BVNKF vs BVNRYBanner chart's image
Bavarian Nordic A/S
Price$21.20
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
Bavarian Nordic A/S
Price$8.65
Change+$0.27 (+3.22%)
Volume$1.29K
CapitalizationN/A
View a ticker or compare two or three
BVNKF vs BVNRY Comparison Chart

Loading...

VS
BVNKF vs. BVNRY commentary
May 18, 2024

To understand the difference between Bavarian Nordic A/S (BVNKF) vs. Bavarian Nordic A/S - ADR (BVNRY) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

COMPARISON
Comparison
May 18, 2024
Stock price -- (BVNKF: $21.20 vs. BVNRY: $8.65)
Brand notoriety: BVNKF and BVNRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNKF: 130% vs. BVNRY: 31%
Market capitalization -- BVNKF: $1.97B vs. BVNRY: $1.97B
BVNKF [@Biotechnology] is valued at $1.97B. BVNRY’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNKF’s FA Score shows that 0 FA rating(s) are green whileBVNRY’s FA Score has 0 green FA rating(s).

  • BVNKF’s FA Score: 0 green, 5 red.
  • BVNRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both BVNKF and BVNRY are a bad buy in the long-term.

Price Growth

BVNKF (@Biotechnology) experienced а 0.00% price change this week, while BVNRY (@Biotechnology) price change was +11.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BVNKF with price predictions.
OPEN
A.I.dvisor published
a Summary for BVNRY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BVNKF($1.97B) and BVNRY($1.97B) have the same market capitalization . BVNRY has higher P/E ratio than BVNKF: BVNRY (14.11) vs BVNKF (11.53). BVNRY YTD gains are higher at: -1.115 vs. BVNKF (-19.161).
BVNKFBVNRYBVNKF / BVNRY
Capitalization1.97B1.97B100%
EBITDAN/AN/A-
Gain YTD-19.161-1.1151,719%
P/E Ratio11.5314.1182%
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BVNKF vs BVNRY: Fundamental Ratings
BVNKF
BVNRY
OUTLOOK RATING
1..100
3630
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
9676
SMR RATING
1..100
8686
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
9897
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVNKF's Valuation (46) in the null industry is in the same range as BVNRY (50). This means that BVNKF’s stock grew similarly to BVNRY’s over the last 12 months.

BVNRY's Profit vs Risk Rating (76) in the null industry is in the same range as BVNKF (96). This means that BVNRY’s stock grew similarly to BVNKF’s over the last 12 months.

BVNRY's SMR Rating (86) in the null industry is in the same range as BVNKF (86). This means that BVNRY’s stock grew similarly to BVNKF’s over the last 12 months.

BVNRY's Price Growth Rating (50) in the null industry is in the same range as BVNKF (50). This means that BVNRY’s stock grew similarly to BVNKF’s over the last 12 months.

BVNRY's P/E Growth Rating (97) in the null industry is in the same range as BVNKF (98). This means that BVNRY’s stock grew similarly to BVNKF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGFFX39.750.11
+0.28%
Sparrow Growth A
FRBSX35.670.04
+0.11%
Franklin Mutual U.S. Mid Cap Value A
AUUCX18.770.02
+0.11%
AB Select US Equity C
DREVX18.72N/A
N/A
BNY Mellon Large Cap Securities Inc
TCRAX51.83-0.01
-0.02%
American Century Growth A